KLP Kapitalforvaltning’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
KLP Kapitalforvaltning's UPB Position: Q3 2026 in Review
KLP Kapitalforvaltning sold out of Upstream Bio (UPB) in Q3 2026, closing a stake of 5,900 shares — an estimated $40.8K sold.
KLP Kapitalforvaltning first reported a position in UPB in Q4 2025 and held it in 3 quarters. The position peaked at $78.7K in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- KLP Kapitalforvaltning reported no remaining Upstream Bio position as of Q3 2026 after selling out during the quarter.
- KLP Kapitalforvaltning sold 5,900 Upstream Bio shares in Q3 2026, an estimated $40.8K.
- KLP Kapitalforvaltning first reported a position in Upstream Bio in Q4 2025 and held it in 3 quarters.
- KLP Kapitalforvaltning's Upstream Bio position peaked at $78.7K in Q4 2025.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.